Company intelligence / Profile preview

Toro Neurovascular

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

Toro Neurovascular is an active, privately held company developing advanced catheter-based medical devices for acute ischemic stroke. Their lead product, the Toro 88 SuperBore Aspiration Catheter, utilizing MicroFlex Technology, is in clinical study in Japan, demonstrating successful, efficient clot removal and restoration of blood flow. The device is not yet commercially available but plans for commercial launch with US and Japan distribution partnerships and pre-orders are in place.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Undisclosed US strategic distributorUndisclosed Japan distribution partner

Beyond the preview

Go deeper on Toro Neurovascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toro Neurovascular.

Explore the full profile